Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BCAB

BioAtla Inc

May 22 • 04:00PM ET

3.69

+0.08 2.07 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: SABS IMNN BCTX BLRX HOTH

| Held by: VTI VXF BTEC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-41.83	Insider Own	16.78%	Shs Outstand	1.66M	Perf Week	-13.58%
Market Cap	6.12M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	1.38M	Perf Month	-28.49%
Enterprise Value	10.25M	PEG	-	EPS next Q	-	Inst Own	12.71%	Short Float	10.67%	Perf Quarter	-61.10%
Income	-50.62M	P/S	3.06	EPS this Y	-	Inst Trans	3.84%	Short Ratio	3.82	Perf Half Y	-93.64%
Sales	2.00M	P/B	-	EPS next Y	-	ROA	-216.05%	Short Interest	0.15M	Perf YTD	-87.00%
Book/sh	-22.48	P/C	3.12	EPS next 5Y	-	ROE	-813.88%	52W High	71.50 -94.84%	Perf Year	-81.86%
Cash/sh	1.18	P/FCF	-	EPS past 3/5Y	28.18% 0.99%	ROIC	-	52W Low	3.26 13.19%	Perf 3Y	-97.89%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- 36.06%	Gross Margin	84.50%	Volatility	15.16% 11.44%	Perf 5Y	-99.83%
Dividend TTM	-	EV/Sales	5.12	EPS Y/Y TTM	31.28%	Oper. Margin	-2524.95%	ATR (14)	0.55	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.15	Sales Y/Y TTM	-81.82%	Profit Margin	-2530.85%	RSI (14)	34.94	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.15	EPS Q/Q	67.91%	SMA20	-13.09%	Beta	0.77	Target Price	52.00
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-33.58%	Rel Volume	0.44	Prev Close	3.62
Employees	41	LT Debt/Eq	-	Earnings	Mar 31 AMC	SMA200	-83.19%	Avg Volume	38.55K	Price	3.69
IPO	Dec 16, 2020	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	16,929	Change	2.07%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)